These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 26905124

  • 1. Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients.
    Mir R, Ahmad I, Javid J, Zuberi M, Yadav P, Shazia R, Masroor M, Guru S, Ray PC, Gupta N, Saxena A.
    Indian J Cancer; 2015; 52(3):314-8. PubMed ID: 26905124
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M, Ghaffari SH, Ghavamzadeh A, Alimoghaddam K, Jahani M, Mousavi SA, Irvani M, Bahar B, Bibordi I.
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
    Muddathir AM, Kordofani AA, Fadl-Elmula IM.
    Saudi Med J; 2013 Jan; 34(1):29-33. PubMed ID: 23299156
    [Abstract] [Full Text] [Related]

  • 7. Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India.
    Anand MS, Varma N, Varma S, Rana KS, Malhotra P.
    Indian J Med Res; 2012 Jan; 135(1):42-8. PubMed ID: 22382182
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
    Bennour A, Ouahchi I, Moez M, Elloumi M, Khelif A, Saad A, Sennana H.
    Clin Lab; 2012 Jan; 58(5-6):433-9. PubMed ID: 22783572
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients.
    Khazaal MS, Hamdan FB, Al-Mayah QS.
    Mol Genet Genomic Med; 2019 Aug; 7(8):e809. PubMed ID: 31206255
    [Abstract] [Full Text] [Related]

  • 13. Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts.
    Sharma P, Kumar L, Mohanty S, Kochupillai V.
    Ann Hematol; 2010 Mar; 89(3):241-7. PubMed ID: 19714331
    [Abstract] [Full Text] [Related]

  • 14. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X, Pan J, Qiu H, Cen J, Xue Y, Chen S, Shen H, Yao L, Zhang J, Wu Y, Chen Y.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
    [Abstract] [Full Text] [Related]

  • 15. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
    Udomsakdi-Auewarakul C, U-Pratya Y, Boonmoh S, Vatanavicharn S.
    J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
    [Abstract] [Full Text] [Related]

  • 16. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
    Haaß W, Kleiner H, Weiß C, Haferlach C, Schlegelberger B, Müller MC, Hehlmann R, Hofmann WK, Fabarius A, Seifarth W, Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung, German CML Study Group.
    PLoS One; 2015 Aug; 10(6):e0129648. PubMed ID: 26087013
    [Abstract] [Full Text] [Related]

  • 17. Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia.
    de Lemos JA, de Oliveira CM, Scerni AC, Bentes AQ, Beltrão AC, Bentes IR, Azevedo TC, Maradei-Pereira LM.
    Genet Mol Res; 2005 Dec 30; 4(4):803-11. PubMed ID: 16475128
    [Abstract] [Full Text] [Related]

  • 18. Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia.
    Bock O, Reising D, Kreipe H.
    Diagn Mol Pathol; 2003 Sep 30; 12(3):119-23. PubMed ID: 12960692
    [Abstract] [Full Text] [Related]

  • 19. BCR-ABL Gene Transcript Types of Patients with Chronic Myelogenous Leukemia in Yogyakarta, Indonesia.
    Paramita DK, Hutajulu SH, Syifarahmah A, Sholika TA, Fatmawati S, Aning S, Sulistyawati D, Wahyuni S, Taroeno-Hariadi KW, Kurnianda J.
    Asian Pac J Cancer Prev; 2020 Jun 01; 21(6):1545-1550. PubMed ID: 32592347
    [Abstract] [Full Text] [Related]

  • 20. Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia.
    Lin HX, Sjaarda J, Dyck J, Stringer R, Hillis C, Harvey M, Carter R, Ainsworth P, Leber B, Pare G, Sadikovic B.
    Eur J Haematol; 2016 Apr 01; 96(4):360-6. PubMed ID: 26059983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.